NuVasive | NUVA - أصول متداولة



أصول متداولة تغيير تاريخ
Abbott USD 26B 1.16B 2025-12
AtriCure USD 322.52M 21.41M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.74B 380M 2025-12
Globus Medical USD 2.13B 201.25M 2025-12
Haemonetics USD 943.67M 43.99M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.04B 54.62M 2025-12
Orthofix International USD 416.85M 22.68M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12